Table: OncoTherapy Science - 6-MTH group results

OncoTherapy Science

04/11/2022 08:00

Nov 4 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2022        Sep 30, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            514 mln             240 mln                    
                (+113.9 pct)        (+138.6 pct)                  
  Operating     loss 618 mln        loss 948 mln                  
  Recurring     loss 643 mln        loss 952 mln                  
  Net           loss 613 mln          loss 1.23                   
  EPS           loss 3.19 yen       loss 6.74 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T